Combination therapy in malaria: orientations and options for the African Region

Sukwa, Thomas; Were, Wilson M.; Kassankogno, Yao; Kabore, B. Antoine.
Brazzaville; World Health Organization. Regional Office for Africa; 2004.
| WHOLIS | ID: who-358073

Documentos relacionados

  1. Role of riboflavin deficiency in malaria pathophysiology.
  2. Knowledge, compliance, and challenges in anti-malarial products usage: a systematic review of at-risk communities for zoonotic malaria.
  3. From efficacy to effectiveness: a comprehensive framework for monitoring, evaluating and optimizing seasonal malaria chemoprevention programmes.
  4. Isoliensinine from Cissampelos pariera rhizomes exhibits potential gametocytocidal and anti-malarial activities against Plasmodium falciparum clinical isolates.
  5. Defining the next generation of severe malaria treatment: a target product profile.
  6. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda.
  7. Staging an Antibody Contest to Fight Malaria.
  8. Recent developments in the synthesis of hybrid antimalarial drug discovery.
  9. Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum.
  10. Clearing of hemozoin crystals in malaria parasites enables whole-cell STED microscopy.